Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Accuray Incorporated (ARAY)

Accuray Incorporated (ARAY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 157,413
  • Shares Outstanding, K 90,467
  • Annual Sales, $ 418,790 K
  • Annual Income, $ -16,430 K
  • 60-Month Beta 1.94
  • Price/Sales 0.36
  • Price/Cash Flow N/A
  • Price/Book 2.65

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate -0.02
  • Number of Estimates 3
  • High Estimate 0.00
  • Low Estimate -0.05
  • Prior Year -0.01
  • Growth Rate Est. (year over year) -100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3300 +42.86%
on 03/25/20
3.1900 -40.44%
on 03/03/20
-1.0650 (-35.92%)
since 02/28/20
3-Month
1.3300 +42.86%
on 03/25/20
4.6800 -59.40%
on 01/29/20
-0.9200 (-32.62%)
since 12/27/19
52-Week
1.3300 +42.86%
on 03/25/20
4.8300 -60.66%
on 04/01/19
-2.8700 (-60.17%)
since 03/29/19

Most Recent Stories

More News
Why You Should Invest in Cardinal Health (CAH) Stock Now

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment, diversified product portfolio and strategic buyouts.

SYK : 166.49 (+2.17%)
ARAY : 1.9000 (+9.20%)
CAH : 47.94 (-1.03%)
COO : 275.67 (-1.60%)
Here's Why You Should Invest in DaVita (DVA) Stock Right Now

DaVita (DVA) continues to gain traction from strong international foothold, strategic buyout of dialysis centers and DaVita Kidney Care.

ARAY : 1.9000 (+9.20%)
DVA : 76.06 (-0.46%)
COO : 275.67 (-1.60%)
WST : 152.25 (+0.29%)
Here's Why You Should Hold On to PerkinElmer (PKI) Stock Now

PerkinElmer (PKI) expects to witness foreign exchange headwinds in 2020.

SYK : 166.49 (+2.17%)
ARAY : 1.9000 (+9.20%)
PKI : 75.28 (-1.61%)
COO : 275.67 (-1.60%)
Here's Why You Should Hold On to Inogen (INGN) Stock for Now

Inogen (INGN) expects to report a loss per share in the first quarter of 2020.

SYK : 166.49 (+2.17%)
ARAY : 1.9000 (+9.20%)
COO : 275.67 (-1.60%)
INGN : 51.66 (+0.47%)
Here's Why You Should Retain Merit Medical (MMSI) Stock Now

Merit Medical (MMSI) continues to benefit from growing product pipeline, strong R&D focus and strategic acquisitions.

ARAY : 1.9000 (+9.20%)
MMSI : 31.25 (+1.10%)
COO : 275.67 (-1.60%)
WST : 152.25 (+0.29%)
Here's Why Investors Should Buy Masimo (MASI) Stock Now

Masimo (MASI) sees a slew of developments lately.

SYK : 166.49 (+2.17%)
ARAY : 1.9000 (+9.20%)
MASI : 177.12 (-1.47%)
COO : 275.67 (-1.60%)
Masimo & University Hospitals Unite for Patient Monitoring

Masimo (MASI) sees a plethora of developments lately.

SYK : 166.49 (+2.17%)
ARAY : 1.9000 (+9.20%)
MASI : 177.12 (-1.47%)
COO : 275.67 (-1.60%)
PRA Health's New Program to Lend Support to Healthcare System

PRA Health's (PRAH) COVID-19 Monitoring Program will allow individuals to connect with a healthcare professional remotely while maintaining social distancing.

BDX : 229.77 (+3.10%)
ARAY : 1.9000 (+9.20%)
COO : 275.67 (-1.60%)
PRAH : 83.04 (-0.50%)
Here's Why You Should Hold on to NextGen Healthcare Stock Now

NextGen Healthcare (NXGN) continues to benefit from growing RCM and EHR markets, and robust demand for other NextGen solutions.

ARAY : 1.9000 (+9.20%)
COO : 275.67 (-1.60%)
WST : 152.25 (+0.29%)
NXGN : 10.44 (+0.10%)
Masimo's Latest Buyout to Boost Respiratory Product Spectrum

Masimo (MASI) expects the transaction to be neutral to 2020 earnings.

SYK : 166.49 (+2.17%)
ARAY : 1.9000 (+9.20%)
MASI : 177.12 (-1.47%)
IDXX : 242.24 (+0.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade ARAY with:

Business Summary

ACCURAY INCORPORATED based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends...

See More

Key Turning Points

2nd Resistance Point 2.0333
1st Resistance Point 1.9667
Last Price 1.9000
1st Support Level 1.7667
2nd Support Level 1.6333

See More

52-Week High 4.8300
Fibonacci 61.8% 3.4930
Fibonacci 50% 3.0800
Fibonacci 38.2% 2.6670
Last Price 1.9000
52-Week Low 1.3300

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar